0001179110-18-002364.txt : 20180220 0001179110-18-002364.hdr.sgml : 20180220 20180220160224 ACCESSION NUMBER: 0001179110-18-002364 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180215 FILED AS OF DATE: 20180220 DATE AS OF CHANGE: 20180220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Enyedy Mark J CENTRAL INDEX KEY: 0001586965 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17999 FILM NUMBER: 18624525 MAIL ADDRESS: STREET 1: C/O FATE THERAPEUTICS, INC. STREET 2: 3535 GENERAL ATOMICS COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOGEN INC CENTRAL INDEX KEY: 0000855654 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042726691 STATE OF INCORPORATION: MA FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 830 WINTER ST CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781)895-0600 MAIL ADDRESS: STREET 1: 830 WINTER ST CITY: WALTHAM STATE: MA ZIP: 02451 4 1 edgar.xml FORM 4 - X0306 4 2018-02-15 0 0000855654 IMMUNOGEN INC IMGN 0001586965 Enyedy Mark J 24 CONCORD SQUARE BOSTON MA 02118 1 1 0 0 Chief Executive Officer Stock Option (right to buy) 10.65 2018-02-15 4 A 0 1100000 10.65 A 2019-02-15 2028-02-15 Common Stock 1100000 1100000 D Exercisable in three equal installments over three years starting on the first year anniversary of the grant. /s/ Craig Barrows, attorney in fact 2018-02-20